A second pedigree with autosomal dominant nemaline myopathy caused by TPM3 mutation: a clinical and pathological study

Neuromuscul Disord. 2007 Apr;17(4):330-7. doi: 10.1016/j.nmd.2007.01.017. Epub 2007 Mar 21.

Abstract

The slow alpha-tropomyosin (TPM3) gene has to date been associated with few cases of both dominant and recessive nemaline myopathies. We report the identification of a p.Arg167His mutation in a four-generation family presenting with a mild classical form of the disease. Clinically, there was no correlation between the age at presentation and the severity of the disease. The dominant-negative p.Arg167His mutation is a recurrent mutation, previously reported in one sporadic case. Histological studies showed discrepancy between the two reports. While a type II fibre predominance was described in the sporadic case, we observed an almost complete type I fibre predominance. This study emphasizes the variability in histopathological phenotypes seen with TPM3 mutations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Arginine / genetics
  • Family Health
  • Female
  • Histidine / genetics
  • Humans
  • Male
  • Microscopy, Electron, Transmission / methods
  • Middle Aged
  • Muscle, Skeletal / metabolism
  • Muscle, Skeletal / pathology
  • Muscle, Skeletal / ultrastructure
  • Mutation*
  • Myopathies, Nemaline / etiology
  • Myopathies, Nemaline / genetics*
  • Myopathies, Nemaline / pathology
  • Pedigree*
  • Tropomyosin / genetics*

Substances

  • TPM3 protein, human
  • Tropomyosin
  • Histidine
  • Arginine